Skip to main content
Caplight Logo









RyboDyn, Inc.

RyboDyn, Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://rybodyn.com/

Last Round

Seed

Mar 24, 2026

Total Funding Raised

$14M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RyboDyn, Inc. is a biotechnology company that develops first-in-class immunotherapies by decoding the dark proteome using an AI-powered sequencing and discovery platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryimmunotherapyAI drug discoverydark proteomeantibody therapeuticsAI-driven discoveryoncologytranscriptomicsproteomicsbiotechin silico drug discoveryprecision medicineRNA sequencingtherapeutic targetsdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RyboDyn, Inc. Comparables

Compare RyboDyn, Inc. with similar companies based on industry and business-model similarity.

RyboDyn, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amaroq Therapeutics
86%
ProFound Therapeutics
82%
Enara Bio
79%

RyboDyn, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 24, 2026
Pre SeedJan 9, 2025

Key People

Founding team and executive leadership

Imad Ajjawi

CEO and Co-Founder

Founding Team

Corey Dambacher

President and CTO

Executive Team

RyboDyn, Inc. Investors

Notable investors and investment history

RyboDyn, Inc. investors
InvestorRounds
SeaX VenturesSeed, Pre Seed
P2 VenturesSeed
P2 Capital PartnersSeed
Swell VCPre Seed, Seed
SOSVPre Seed, Seed
Massive Tech VenturesSeed
GenedantSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 106% MoM.

  • Mar 24, 2026

    $10M raised in Seed round.

RyboDyn, Inc. Filings

Explore SEC and related filing metadata, where available.

RyboDyn, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RyboDyn, Inc.'s valuation, stock price, and market status.

Is RyboDyn, Inc. a public or private company?

RyboDyn, Inc. is a private company.

What is the current stock price of RyboDyn, Inc.?

RyboDyn, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is RyboDyn, Inc. worth (valuation)?

Valuation information for RyboDyn, Inc. is not publicly available.

Can I buy RyboDyn, Inc. stock?

RyboDyn, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RyboDyn, Inc.'s last funding round?

RyboDyn, Inc.'s most recent funding round was Seed on March 24, 2026.

Who are the main investors in RyboDyn, Inc.?

Key investors in RyboDyn, Inc. include SeaX Ventures, Genedant.

Will RyboDyn, Inc. IPO soon?

No public IPO plans have been announced for RyboDyn, Inc..

How can I track RyboDyn, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RyboDyn, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range13
Year Founded2022
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?